ArticlePloS one2017

Gastrointestinal cancer cells treatment with bevacizumab activates a VEGF autoregulatory mechanism involving telomerase catalytic subunit hTERT via PI3K-AKT, HIF-1α and VEGF receptors.

Nadine Mahfouz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.